Telecare in Type 1 Diabetes (T1D) Patients Treated by Insulin Pump
Telecare in Type 1 Diabetes (T1D) Patients Treated by Insulin Pump
The purpose of this study is to determine whether Telecare can be used for efficient
 management of adults with Type 1 Diabetes Mellitus using insulin pump, in lieu of frequent
 clinic visits.
1. Objectives

 1. To evaluate the effect of telecare on glycemic control for patients with type 1
 diabetes (T1DM).

 2. To assess the cost of telecare to Maccabi, the patient and the economy.

 3. To assess patients' quality of life and satisfaction with telecare intervention.

 4. To assess the effect of telecare intervention on insulin adjustment to consumed
 carbohydrates.

 2. Working hypothesis Telecare can be used for efficient management of T1DM in adults using
 insulin pump, in lieu of frequent clinic visits.

 3. Methodology A randomized controlled prospective trial for one year. Intervention group:
 Each patient will transmit glucometer and pump data electronically via a web site
 (Medtronic Carelink internet site www.carelink.minimed.com) to diabetes team and will
 receive feedback by telephone. Frequency of data transfer will be directly related to
 patients' metabolic control. In addition to data transmission Patient of the
 intervention group will be arriving during the intervention year for 3 clinic visit at
 the following time point : 0, 6 and 12 month.

 Control group: 3-month routine clinic visits

 4. Significance of the proposed research (its uniqueness and innovation) Telecare
 potentially offers a method for efficient continuous care management of patients with
 T1DM using insulin pump in lieu of clinic visits. It enables real time responses of
 clinical personnel and increases patient involvement. This trial will be the first
 telecare intervention lasting for one year to determine if treatment is as efficient as
 face to face visits, thus enabling cost reduction and time saving without affecting the
 quality of care. .
Inclusion Criteria:

 -  Patients with T1D lasted >1 year, age 22 and up, using insulin pump

 -  Patients possessing a mobile phone and internet access

 Exclusion Criteria:

 -  Patients with Severe target organ damage

 -  Patients with Mental retardation

 -  Patients with Eating disorders

 -  Pregnant patients or patients planning pregnancy